Isolation of quinupristin/dalfopristin-resistant Streptococcus agalactiae from asymptomatic Korean women

Journal of Microbiology

Volumn 46, Issue 1, 2008, Pages 108-111

  Nam, Hye Ran ^a   Lee, Hak Mee ^a   Lee, Yeonhee ^a  

^a Seoul Women University   (South Korea)

Author keywords

Antimicrobial resistance; Multi drug resistance; Quinupristin dalfopristin; Streptococcus agalactiae; Vagina

Indexed keywords

STREPTOCOCCUS AGALACTIAE;

ANTIINFECTIVE AGENT; BACTERIAL DNA; DALFOPRISTIN PLUS QUINUPRISTIN; QUINUPRISTIN-DALFOPRISTIN; RIBOSOME DNA; RNA 16S; VIRGINIAMYCIN;

ADULT; ARTICLE; DRUG EFFECT; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KOREA; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; VAGINA SMEAR;

ADULT; ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; DNA, RIBOSOMAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; KOREA; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RNA, RIBOSOMAL, 16S; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VAGINAL SMEARS; VIRGINIAMYCIN;

EID: 43249111796     PISSN: 12258873     EISSN: 12258873     Source Type: Journal    
DOI: 10.1007/s12275-007-0217-1     Document Type: Article

References (22)

1. th ed. NCCLS document M7-A6. NCCLS, Wayne, PA, USA.
2. Clinical Laboratory Standards Institute. 2004. Performance standards for antimicrobial disk susceptibility testing. Fourteenth informational supplement. NCCLS document M100-514. NCCLS, Wayne, PA, USA.
3. Culebras, E., I. Rodriguez-Avial, C. Betriu, M. Redondo, and J.J. Picazo. 2002. Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae. Antimicrob. Agents Chemother. 46, 1574-1576.
4. Diekema, D.J., J.I. Andrews, H. Huynh, P.R. Rhomberg, S.R. Doktor, J. Beyer, V.D. Shortridge, R.K. Flamm, R.N. Jones, and M.A. Pfaller. 2003. Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci. J. Clin. Microbiol. 41, 2659-2661.
5. Dowzicky, M., H.L. Nadler, C. Feger, G. Talbot, F. Bompart, and M. Pease. 1998. Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates. Am. J. Med. 104, 34S-42S.
6. Farley, M.M. 2001. Group B streptococcal disease in non pregnant adults. Clin. Infect. Dis. 33, 556-561.
7. Glaser, P., C. Rusniok, C. Buchrieser, F. Chevalier, L. Frageul, T. Msadek, M. Zouine, E. Couve, L. Lalioui, C. Poyart, P. Trieu-Cout, and F. Kunst. 2002. Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol. Microbiol. 45, 1499-1513.
8. AL, p. 1043-1071. In P.H.A. Sneath, N.S. Mair, M.E. Sharpe, and J.G. Holt (eds.), Bergey's manual of systematic bacteriology, Vol. 2. Williams & Wilkins, Baltimore, MD, USA.
9. Heelan, J.S., M.E. Hasenbein, and A.J. McAdam. 2004. Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin. J. Clin. Microbiol. 42, 1263-1264.
10. Henning, K.J., E.L. Hall, and D.M. Dwyer. 2001. Invasive group B streptococcal disease in Maryland nursing home residents. J. Infect. Dis. 183, 1138-1142.
11. Malbruny, B., A.M. Werno, T.P. Anderson, D.R. Murdoch, and R. Leclercq. 2004. A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand. J. Antimicrob. Chemother. 54, 1040-1044.
12. Manson, J.M., S. Keis, J.M.B. Smith, and G.M. Cook. 2003. A clonal lineage of VanA-type Enterococcus faecalis predominates in vancomycin-resistant enterococci isolated in New Zealand. Antimicrob. Agents Chemother. 47, 204-210.
13. Marchese, A., E.A. Debbia, and G.C. Schito. 1999. In vitro activity of quinupristin/dalfopristin against selected bacterial pathogens isolated in Italy. Clin. Microbiol. Infect. 5, 488-495.
14. Murdoch, D.R. and L.B. Reller. 2001. Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10 year perspective. Antimicrob. Agents Chemother. 45, 3623-3624.
15. Onderdonk, A.B. and W.W. Wissemann. 1993. Normal vaginal microbiota, p. 285-304. In P. Elsner and J. Martins (eds.), Vulvovaginitis. Marcel Dekker Inc., New York, NY, USA.
16. Pechere, J.C. 1992. In vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci. J. Antimicrob. Chemother. 30, 15-18.
17. Redondo-Lopez, V., R.L. Cook, and J.D. Sobel. 1990. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microbiota. Rev. Infect. Dis. 12, 856-872.
18. th ed. ASM Press, Washington, D.C., USA.
19. Simonsen, G.S., K. Bergh, L. Bevanger, A. Digranes, P. Gaustad, K.K. Melby, and E.A. Hoiby. 2004. Susceptibility to quinupristin-dalfopristin and linezolid in 839 clinical isolates of Gram-positive cocci from Norway. Scand. J. Infect. Dis. 36, 254-258.
20. Suzuki, M.T. and S.J. Giovannoni. 1996. Bias caused by template annealing in the amplification of mixtures of 16S rRNA genes by PCR. Appl. Environ. Microbiol. 62, 625-630.
21. Uh, Y., G.Y. Hwang, I.H. Jang, H.M. Cho, S.M. Noh, H.Y. Kim, O. Kwon, K.J. Yoon. 2007. Macrolide resistance trends in beta-hemolytic streptococci in a tertiary Korean hospital. Yonsei Med. J. 48, 773-778.
22. Wu, J.J., K.Y. Lin, P.R. Hsueh, J.W. Liu, H.I. Pan, and S.M. Sheu. 1997. High incidence of erythromycin-resistant streptococci in Taiwan. Antimicrob. Agents Chemother. 41, 844-846.